Provepharm
FranceWho owns Provepharm?
Provepharm is a French Biotech company, currently owned by Région Sud Investissement since 2026 and ARCHIMED. It changed hands in 2018, when SOFIPACA - Groupe Crédit Agricole sold.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
Ownership history
3 ownership periods
SOFIPACA - Groupe Crédit Agricole sold Provepharm to ArchiMed and Tethys Invest in 2018 after 7 years.
More from RSI 3
Other portfolio companies in the same fund.
More PE-backed in Pharma
Comparable pharma deals from other GPs.
US
SpainQuestions
Who owns Provepharm?
Provepharm is currently owned by Région Sud Investissement and ARCHIMED, through RSI 3, since 2026.
When did Région Sud Investissement and 1 other acquire Provepharm?
Région Sud Investissement and 1 other acquired Provepharm in 2026.
Who did Provepharm sell to?
SOFIPACA - Groupe Crédit Agricole sold Provepharm to ArchiMed and Tethys Invest in 2018 (Secondary).
Who has owned Provepharm over time?
Provepharm has been through 3 private-equity ownership periods: SOFIPACA - Groupe Crédit Agricole · via SOFIPACA Evergreen · 2011–2018 · sold to ArchiMed and Tethys Invest · (Secondary); ARCHIMED · via MED II · since 2018; Région Sud Investissement · via RSI 3 · since 2026.